Atlas Trials

Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population

Clinical trial NCT03468309 · COMPLETED

Trial details

NCT number
NCT03468309
Sponsor
Seattle Institute for Biomedical and Clinical Research
Status
COMPLETED
Study type
OBSERVATIONAL
Pharmacogenetic Testing
Start date
2018-01-01
Primary completion
2019-04-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.